Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity-Reference-Cited by-同舟云学术

Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity

Published:2023-10 Issue: Volume:573 Page:216370
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Qiao Wen,Hu Cegui,Ma Jiayi,Dong Xinrui,Dalangood Sumiya,Li Hanjun^ORCID,Yuan Chenwei,Lu Binbin,Gao Wei-Qiang,Wen Zhenke^ORCID,Yin Wenjin,Gui Jun^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference53 articles.

1. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities;Kim;Nat. Rev. Drug Discov.,2022

2. Immune checkpoint blockade in cancer therapy;Postow;J. Clin. Oncol.,2015

3. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N. Engl. J. Med.,2018

4. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer;Horn;N. Engl. J. Med.,2018

5. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study;Burtness;Lancet,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in and prospects of immunotherapy for prostate cancer;Cancer Letters;2024-10

2. Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantation;Cancer Letters;2024-10

3. Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction;Cancer Letters;2024-08

4. Perillaldehyde ameliorates lipopolysaccharide-induced acute lung injury via suppressing the cGAS/STING signaling pathway;International Immunopharmacology;2024-03

5. Bcl-xL mediates interferon-beta secretion by protease-activated receptor 2 deficiency through the mitochondrial permeability transition pore in colorectal cancer metastasis;Cancer Letters;2024-01